Do patients with primary pulmonary hypertension develop extensive central thrombi ?

• Published in: Circulation (New York, N.Y.) N.Y.), 1995-02, Vol.91 (3), p.741-745
• Main Authors: MOSER, K. M, FEDULLO, P. F, FINKBEINER, W. E, GOLDEN, J
• Format: Article
• Language: English
• Subjects: Adult; Aged; Biological and medical sciences; Chronic Disease; Diagnosis, Differential; Female; Humans; Hypertension, Pulmonary - complications; Male; Medical sciences; Middle Aged; Pneumology; Pulmonary Artery; Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases; Thrombosis - etiology
• ISSN: 0009-7322; 1524-4539
• DOI: 10.1161/01.cir.91.3.741

Distinguishing chronic major vessel thromboembolic pulmonary hypertension from primary pulmonary hypertension is critical because the treatment options differ markedly. Surgical thromboendarterectomy is potentially curative in the former condition, whereas oxygen, vasodilators, perhaps anticoagulation, and lung transplantation are the options for the latter. The development of large thrombi in the main, right, or left pulmonary arteries has not been previously described in patients with primary pulmonary hypertension. Three pulmonary hypertensive patients with massive thrombi in the central pulmonary arteries are described. The data indicate that the large central thrombi in these three patients were not hemodynamically significant. In none did perfusion lung scans demonstrate segmental or larger defects. Large central thrombi can develop in patients with primary pulmonary hypertension. Perfusion lung scans that do not demonstrate segmental or larger defects should alert physicians to this possibility. Chest computed tomography and other studies identifying such thrombi are not adequate in distinguishing such a development from operable chronic major vessel thromboembolic hypertension. Careful review of lobar and segmental artery findings and the pulmonary angiogram, angioscopy, and cardiac catheterization data demonstrating the hemodynamic significance (or lack thereof) of these thrombi are essential in making this important distinction. Furthermore, these observations may constitute an additional indication for anticoagulant therapy in primary pulmonary hypertension.